The Key to SDOH: Health literacy

social determinants of health,
By all accounts, Covid-19 has amplified the discussion around critical health disparities and inequities that have plagued the United States and its most vulnerable patient populations for generations. The past year has exposed how disease does in fact discriminate, and that socioeconomic challenges exacerbate the symptoms of illness. As a result, the healthcare...

4 strategies for healthcare providers to make virtual care practical for seniors

Telemedicine and virtual care are no longer optional for healthcare practices. Covid-19 catapulted virtual care from an ancillary service to a staple of modern healthcare and has shown to be a positive addition for all parties involved. In fact, Deloitte predicted Medicare Advantage plans that don’t embrace telehealth “will get left behind.” The Centers...

LifePoint Health, Eon strike partnership to advance early diagnoses

An early, and accurate, diagnosis can help clinicians catch diseases in their initial stages, making treatment more effective. This is precisely why Brentwood, Tennessee-based LifePoint Health and health technology company Eon have entered into a five-year agreement. Together, they will develop new solutions to drive the earlier detection of diseases, said Bart Daugherty, assistant...

Merck’s Covid-19 drug R&D falls short twice in treating hospitalized patients

  Merck is stopping development of two drugs as potential treatments for hospitalized Covid-19 patients, and one of those medicines will move forward in clinical testing only as a potential outpatient therapy. The drug that will be completely dropped, MK-7110, is a fusion protein that Merck added to its pipeline via its $425 million...

Thermo Fisher’s $21B deal for PPD gives it missing piece in drug development cycle

Putting puzzle pieces together on sky background with sunlight merger
  Thermo Fisher Scientific sells the laboratory equipment that biopharmaceutical companies use in the research and development of new drugs. Its $20.9 billion acquisition of PPD will give the company the global infrastructure to run the clinical trials that test them. Waltham, Massachusetts-based Thermo Fisher announced Thursday that it has agreed to pay $47.50...